This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Model for Cancer Development and Progression

Barry D. Nelkin, PhD; Andrée C. de Bustros, MD; Mack Mabry, MD; Stephen B. Baylin, MD

JAMA. 1989;261(21):3130-3135.

Abstract
Medullary thyroid carcinoma (MTC) is an important human cancer for the study of molecular abnormalities that underlie initiation of neoplasia and subsequent cellular changes during tumor progression. This tumor can occur in different inherited forms, each mediated by autosomal dominant genetic events. Germline abnormalities on chromosome 10 are linked to at least one type of genetic MTC, multiple endocrine neoplasia type II. Our studies of chromosome 10 in DNA from MTC tumors failed to detect frequent loss of polymorphic DNA markers, suggesting that the genetic mechanisms involved in MTC development may be different from those for other inherited cancers such as retinoblastoma. During tumor progression of MTC, abnormalities develop in expression of the mature phenotype of the endocrine cell from which the tumor arises. In cell culture, chemical modulation or gene insertion can lead to partial correction of these defects in differentiation capacity by activating cellular signaling processes. These studies offer opportunities to dissect the molecular events that regulate endocrine cell differentiation, to determine the precise abnormalities that may underlie the initiation and tumor progression events in MTC and related cancers, and, thereby, to identify new targets for therapeutic intervention.

(JAMA. 1989;261:3130-3135)

Author Affiliations
From the Oncology Center (Drs Nelkin, de Bustros, Mabry, and Baylin) and the Department of Medicine (Drs de Bustros and Baylin), The Johns Hopkins Medical Institutions, Baltimore, Md.

Footnotes
Reprint requests to The Johns Hopkins Oncology Center, 424 N Bond St, Baltimore, MD 21231 (Dr Nelkin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The MDM2 Oncoprotein Promotes Apoptosis in p53-Deficient Human Medullary Thyroid Carcinoma Cells
Dilla et al.
Endocrinology 2000;141:420-429.
ABSTRACT | FULL TEXT  

Thyroid Cancer: A Lethal Endocrine Neoplasm
Robbins et al.
ANN INTERN MED 1991;115:133-147.
ABSTRACT